Transdermal pentamidine
US5230897A · kind A · utility
96Cited by
8References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 1991 |
| Grant date | Jul 27, 1993 |
| Priority date | — |
| Expiry date | Oct 31, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and transdermal patches comprised of pentamidine and a penetration enhancing amount of a terpene selected from the group consisting of menthol, carvone, carveol, dihydrocarveol, dihydrocarvone, neomenthol, isopulegol, terpene-4-ol, menthone, pulegol, camphor, geraniol, .alpha.-terpineol, citral, linalol, carvacrol, thymol and anethole are disclosed for delivery of a therapeutically effective amount of pentamidine or its pharmaceutically acceptable salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.